Birth weight and subclinical cardiovascular and renal damage in a population-based study (the STANISLAS cohort study)

Marilucy Lopez-Sublet1,2,3, Thomas Merkling3,4, Nicolas Girerd3,4

  • 1AP-HP, Hôpital Avicenne, Centre d'Excellence Européen en Hypertension Artérielle, Service de Médecine Interne.

Insights

Lower birth weight is linked to higher hypertension risk in adulthood. Higher birth weight may increase left ventricular mass and arterial distensibility in adults with normal BMI.

Area of Science:

  • Cardiovascular Epidemiology
  • Perinatal Medicine
  • Genetics

Background:

  • Low birth weight and preterm birth are associated with increased adult cardiovascular disease risk.
  • Early life factors influencing adult cardiovascular and renal damage (CVRD) and hypertension remain under-investigated.

Purpose of the Study:

  • To investigate the association between birth weight and early CVRD markers in adulthood.
  • To estimate the heritability of birth weight within a family-based cohort.

Main Methods:

  • Analysis of 1028 individuals from the STANISLAS cohort (parents/children).
  • Assessment of cardiovascular and renal markers including pulse-wave velocity, central pressure, ambulatory blood pressure, hypertension, diastolic dysfunction, left ventricular mass indexed (LVMI), and kidney damage.
  • Estimation of birth weight heritability using familial data.

Main Results:

  • Birth weight was negatively associated with hypertension (OR 0.61).
  • A nonlinear association was observed between birth weight and LVMI, with higher birth weights linked to increased LVMI.
  • Birth weight positively correlated with arterial distensibility in adults with normal BMI (β 5.09).

Conclusions:

  • Birth weight is a significant predictor of adult hypertension and cardiovascular markers.
  • Higher birth weight is associated with increased LVMI and arterial distensibility in specific adult populations.
  • No significant associations were found between birth weight and other CVRD markers.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
212
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
39
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
36
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
129
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
3.4K
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
300